Tabula Rasa HealthCare Inc (NASDAQ:TRHC) CFO Brian W. Adams purchased 5,391 shares of Tabula Rasa HealthCare stock in a transaction dated Friday, January 12th. The stock was bought at an average price of $14.23 per share, with a total value of $76,713.93. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Tabula Rasa HealthCare Inc (TRHC) traded up $0.54 during trading on Thursday, reaching $34.21. The company had a trading volume of 30,493 shares, compared to its average volume of 282,094. Tabula Rasa HealthCare Inc has a twelve month low of $11.59 and a twelve month high of $36.80. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.66 and a current ratio of 0.73. The stock has a market capitalization of $656.21 and a PE ratio of -201.24.

Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its earnings results on Monday, November 6th. The company reported $0.08 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.06 by $0.02. Tabula Rasa HealthCare had a negative return on equity of 5.58% and a negative net margin of 2.27%. The business had revenue of $33.27 million during the quarter, compared to analysts’ expectations of $31.76 million. During the same period in the previous year, the business earned $0.06 earnings per share. The firm’s revenue was up 37.6% on a year-over-year basis. equities research analysts predict that Tabula Rasa HealthCare Inc will post 0.03 EPS for the current year.

A number of hedge funds have recently modified their holdings of TRHC. Bank of New York Mellon Corp lifted its stake in Tabula Rasa HealthCare by 47.2% during the second quarter. Bank of New York Mellon Corp now owns 19,412 shares of the company’s stock worth $293,000 after purchasing an additional 6,228 shares during the last quarter. Teachers Advisors LLC lifted its stake in Tabula Rasa HealthCare by 203.5% during the second quarter. Teachers Advisors LLC now owns 16,500 shares of the company’s stock worth $248,000 after purchasing an additional 11,063 shares during the last quarter. TIAA CREF Investment Management LLC lifted its stake in Tabula Rasa HealthCare by 206.4% during the second quarter. TIAA CREF Investment Management LLC now owns 24,913 shares of the company’s stock worth $375,000 after purchasing an additional 16,782 shares during the last quarter. New York State Common Retirement Fund lifted its stake in Tabula Rasa HealthCare by 257.0% during the second quarter. New York State Common Retirement Fund now owns 10,000 shares of the company’s stock worth $151,000 after purchasing an additional 7,199 shares during the last quarter. Finally, Northern Trust Corp lifted its stake in Tabula Rasa HealthCare by 97.4% during the second quarter. Northern Trust Corp now owns 95,862 shares of the company’s stock worth $1,443,000 after purchasing an additional 47,306 shares during the last quarter. 31.85% of the stock is owned by hedge funds and other institutional investors.

TRHC has been the subject of several recent research reports. Zacks Investment Research cut Tabula Rasa HealthCare from a “strong-buy” rating to a “hold” rating in a research report on Friday, November 10th. Piper Jaffray Companies restated an “overweight” rating and set a $29.00 target price (up from $20.00) on shares of Tabula Rasa HealthCare in a research report on Wednesday, September 20th. Wells Fargo & Co boosted their target price on Tabula Rasa HealthCare from $21.00 to $27.00 and gave the stock a “market perform” rating in a research report on Thursday, October 19th. BidaskClub cut Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a research report on Friday, December 15th. Finally, Citigroup began coverage on Tabula Rasa HealthCare in a research report on Thursday, January 4th. They set a “buy” rating for the company. Two research analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. Tabula Rasa HealthCare presently has a consensus rating of “Buy” and a consensus price target of $29.78.

TRADEMARK VIOLATION NOTICE: “Brian W. Adams Acquires 5,391 Shares of Tabula Rasa HealthCare Inc (TRHC) Stock” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another site, it was stolen and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.thecerbatgem.com/2018/01/18/brian-w-adams-acquires-5391-shares-of-tabula-rasa-healthcare-inc-trhc-stock.html.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.

Insider Buying and Selling by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.